| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.056 | 0.8 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |